BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 27886616)

  • 1. Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis.
    Shelke AB; Aurangabadkar HU; Bradfield JS; Ali Z; Kumar KS; Narasimhan C
    Int J Cardiol; 2017 Feb; 228():717-722. PubMed ID: 27886616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
    JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
    Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
    J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-Treatment Myocardial
    Subramanian M; Swapna N; Ali AZ; Saggu DK; Yalagudri S; Kishore J; Swamy LTN; Narasimhan C
    JACC Cardiovasc Imaging; 2021 Oct; 14(10):2008-2016. PubMed ID: 33454258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of serial F-18 FDG PET/CT scans in assessing treatment response and predicting relapses in patients with symptomatic sarcoidosis.
    Maturu VN; Rayamajhi SJ; Agarwal R; Aggarwal AN; Gupta D; Mittal BR
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):372-380. PubMed ID: 28079849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis.
    Lee PI; Cheng G; Alavi A
    J Nucl Cardiol; 2017 Feb; 24(1):19-28. PubMed ID: 27813028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A; Pawar S; Govender P; Berman J; Ruberg FL; Miller EJ
    J Nucl Cardiol; 2017 Apr; 24(2):413-424. PubMed ID: 27457527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis.
    Ning N; Guo HH; Iagaru A; Mittra E; Fowler M; Witteles R
    J Card Fail; 2019 Apr; 25(4):307-311. PubMed ID: 30825644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
    Rojulpote C; Bhattaru A; Jean C; Adams SL; Patel V; Vidula MK; Selvaraj S; Dubroff J; Peyster E; Clancy CB; Patterson K; Marchlinski FE; Rossman M; Goldberg L; Bravo PE
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1944-1955. PubMed ID: 36357136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and recurrence in cardiac sarcoidosis: Serial assessment of BMIPP SPECT and FDG-PET.
    Yamamoto A; Nagao M; Watanabe E; Imamura Y; Suzuki A; Fukushima K; Ando K; Nakao R; Sakai A; Momose M; Sakai S; Hagiwara N
    J Nucl Cardiol; 2021 Jun; 28(3):919-929. PubMed ID: 33728571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
    Nanno T; Kobayashi S; Yoshitomi R; Fujii S; Kajii T; Kohno M; Ishiguchi H; Okuda S; Okada M; Suga K; Yano M
    Circ J; 2019 Nov; 83(12):2494-2504. PubMed ID: 31631075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of treatment response in cardiac sarcoidosis based on myocardial
    Frischknecht L; Schaab J; Schmauch E; Yalamanoglu A; Arnold DD; Schwaiger J; Gruner C; Buechel RR; Franzen DP; Kolios AGA; Nilsson J
    Front Immunol; 2023; 14():1286684. PubMed ID: 38077350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
    Vis R; Mathijssen H; Keijsers RGM; van de Garde EMW; Veltkamp M; Akdim F; Post MC; Grutters JC
    J Nucl Cardiol; 2023 Aug; 30(4):1543-1553. PubMed ID: 36640249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and safety of infliximab in cardiac Sarcoidosis.
    Bakker ALM; Mathijssen H; Azzahhafi J; Swaans MJ; Veltkamp M; Keijsers RGM; Akdim F; Post MC; Grutters JC
    Int J Cardiol; 2021 May; 330():179-185. PubMed ID: 33582196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
    Elwazir M; Krause ML; Bois JP; Christopoulos G; Kendi AT; Cooper JLT; Jouni H; Abouezzeddine OF; Chareonthaitawee P; Abdelshafee M; Amin S
    J Card Fail; 2022 Feb; 28(2):247-258. PubMed ID: 34320381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.